Aurinia Pharmaceuticals Inc (US: AUPH) — Healthcare · Share Price, Chart & Market Data
About: Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $16.48 (+3.13%)
AUPHAurinia Pharmaceuticals Inc
Loading watchlist status…
Trade AUPH now
Aurinia Pharmaceuticals Inc share price
AUPH price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 2:53 pm GMT+0
AUPH price performance
4.172%
5D
15.487%
1M
7.362%
YTD
106%
1Y
AUPH price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 2:53 pm GMT+0
AUPH details
AUPH Market Signals